Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.
Musa AM, Mbui J, Mohammed R, Olobo J, Ritmeijer K, Alcoba G, Muthoni Ouattara G, Egondi T, Nakanwagi P, Omollo T, Wasunna M, Verrest L, Dorlo TPC, Musa Younis B, Nour A, Taha Ahmed Elmukashfi E, Ismail Omer Haroun A, Khalil EAG, Njenga S, Fikre H, Mekonnen T, Mersha D, Sisay K, Sagaki P, Alvar J, Solomos A, Alves F. Musa AM, et al. Clin Infect Dis. 2023 Feb 8;76(3):e1177-e1185. doi: 10.1093/cid/ciac643. Clin Infect Dis. 2023. PMID: 36164254 Free PMC article. Clinical Trial.
Post-kala-azar dermal leishmaniasis.
Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. Zijlstra EE, et al. Among authors: musa am. Lancet Infect Dis. 2003 Feb;3(2):87-98. doi: 10.1016/s1473-3099(03)00517-6. Lancet Infect Dis. 2003. PMID: 12560194 Review.
Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.
Kamil AA, Khalil EA, Musa AM, Modabber F, Mukhtar MM, Ibrahim ME, Zijlstra EE, Sacks D, Smith PG, Zicker F, El-Hassan AM. Kamil AA, et al. Among authors: musa am. Trans R Soc Trop Med Hyg. 2003 May-Jun;97(3):365-8. doi: 10.1016/s0035-9203(03)90171-4. Trans R Soc Trop Med Hyg. 2003. PMID: 15228261 Clinical Trial.
Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
Khalil EA, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM. Khalil EA, et al. Among authors: musa am. Clin Exp Immunol. 2005 May;140(2):349-53. doi: 10.1111/j.1365-2249.2005.02768.x. Clin Exp Immunol. 2005. PMID: 15807861 Free PMC article. Clinical Trial.
Visceral leishmaniasis: new health tools are needed.
Hailu A, Musa AM, Royce C, Wasunna M. Hailu A, et al. Among authors: musa am. PLoS Med. 2005 Jul;2(7):e211. doi: 10.1371/journal.pmed.0020211. Epub 2005 Jul 26. PLoS Med. 2005. PMID: 16033309 Free PMC article. Review.
Uncommon clinical presentations of cutaneous leishmaniasis in Sudan.
Elamin EM, Guerbouj S, Musa AM, Guizani I, Khalil EA, Mukhtar MM, Elkadaro AM, Mohamed HS, Ibrahim ME, Abdel Hamid MM, El Azhari M, El Hassan AM. Elamin EM, et al. Among authors: musa am. Trans R Soc Trop Med Hyg. 2005 Nov;99(11):803-8. doi: 10.1016/j.trstmh.2005.04.009. Trans R Soc Trop Med Hyg. 2005. PMID: 16099005
104 results